A case of pulmonary embolism with bad warfarin anticoagulant effects caused by E. coli infection

A case series of the rifampin-warfarin drug interaction: focus on practical warfarin management

(2021) Charlotte S. Yang et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Effect of Hepatitis C Drugs on Blood Coagulability in Patients on Warfarin Using the Medical Information Database Network (MID-NET®) in Japan

(2021) Sono Sawada et al.   Therapeutic Innovation & Regulatory Science

Pulmonary embolism: update on management and controversies

(2020) Lisa Duffett et al.   BMJ-British Medical Journal

A network meta‐analysis of CYP2C9 , CYP2C9 with VKORC1 and CYP2C9 with VKORC1 and CYP4F2 genotype‐based warfarin dosing strategies compared to traditional

(2020) Kannan Sridharan et al.   JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS

Frequency of Common CYP2C9 Polymorphisms and Their Impact on Warfarin Dose Requirement in Pakistani Population

(2016) Aisha Qayyum et al.   CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS

Edoxaban versus Warfarin for the Treatment of Symptomatic Venous Thromboembolism

(2013)   NEW ENGLAND JOURNAL OF MEDICINE

Oral Apixaban for the Treatment of Acute Venous Thromboembolism

(2013) Giancarlo Agnelli et al.   NEW ENGLAND JOURNAL OF MEDICINE

The incidence of pulmonary embolism during deep vein thrombosis

(2013) J D Nielsen   PHLEBOLOGY

Oral Anticoagulant Therapy

(2012) Walter Ageno et al.   CHEST

Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism

(2012)   NEW ENGLAND JOURNAL OF MEDICINE

Multivariate analysis of the relation between diet and warfarin dose

(2011) Morten Arendt Rasmussen et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Structure of a bacterial homologue of vitamin K epoxide reductase

(2010) Weikai Li et al.   NATURE

Estimation of the Warfarin Dose with Clinical and Pharmacogenetic Data

(2009)   NEW ENGLAND JOURNAL OF MEDICINE

Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism

(2009) Sam Schulman et al.   NEW ENGLAND JOURNAL OF MEDICINE

Inhibition of bacterial disulfide bond formation by the anticoagulant warfarin

(2009) R. J. Dutton et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Benefit of Oral Anticoagulant Over Antiplatelet Therapy in Atrial Fibrillation Depends on the Quality of International Normalized Ratio Control Achieved by Centers and Countries as Measured by Time in Therapeutic Range

(2008) Stuart J. Connolly et al.   CIRCULATION